Home
Clinical Resources Search
PQI: Temozolomide (Temodar®) for Glioblastoma Multiforme

Temozolomide (Temodar®) for Glioblastoma Multiforme

Download PQI pdf 0.16MB

Last Updated: May 22, 2024

By: Hassaan Shaikh, PharmD | Emily Brugioni, MD

About this PQI

The purpose of this PQI is a summary of the process for initiating and monitoring oral temozolomide therapy in patients with Glioblastoma Multiforme (GBM).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Brain Cancer Glioblastoma TSK Temodar Temozolomide

PQI

Frequently Searched

Supported by

Temozolomide (Temodar®) for Glioblastoma Multiforme

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI in Action: Proactive Symptom Management in Myelofibrosis

PQI in Action: Sonidegib (Odomzo®) Patient Management

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

S8 E14: Advancing Geriatric Oncology

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Vorasidenib (Voranigo®)

The PQI Podcast S4 Ep 16: Brain Cancer Awareness Month

Treatment Support Kit: Temozolomide

The PQI Podcast S4 Ep 16: Brain Cancer Awareness Month

Treatment Support Kit: Temozolomide

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

PQI: Tivozanib (Fotivda®) for Relapsed or Refractory Advanced Renal Cell Carcinoma

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

Treatment Support Kit: Temozolomide

Treatment Support Kit: Temozolomide

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

Treatment Support Kit: Elranatamab

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer